Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Anesthesiology
|
November 27, 2008
Blood transfusion promotes cancer progression: a critical role for aged erythrocytes
Shir Atzil, Michal Arad, Ariella Glasner, et al.
Progress in Neurobiology
|
June 19, 2012
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Shambhu Bhat, David T Dao, Chantelle E Terrillion, et al.
International Journal of Mental Health Systems
|
February 24, 2024
Mapping awareness-raising and capacity-building materials on developmental disabilities for non-specialists: a review of the academic and grey literature
Elisa Genovesi, Yuan Ishtar Yao, Emily Mitchell, et al.
Psychopharmacology
|
August 19, 2008
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat
Mark D Black, Geoffrey B Varty, Michal Arad, et al.
Molecular Neurodegeneration
|
June 26, 2021
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, et al.
Stem Cell Research & Therapy
|
July 29, 2017
Harvesting multipotent progenitor cells from a small sample of tonsillar biopsy for clinical applications
Raju Khatri, Michal Arad, Timothy Ortlip, et al.
Nature Aging
|
April 28, 2023
Alzheimer's disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis
Raz Dvir-Szternfeld, Giulia Castellani, Michal Arad, et al.
Oncogene
|
June 9, 2020
ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype
Benjamin A Portney, Michal Arad, Aditi Gupta, et al.
Psychopharmacology
|
December 25, 2010
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
Mark D Black, Rachel J Stevens, Nancy Rogacki, et al.
Oncology Nursing Forum
|
June 21, 2017
Attitudes Among Nurses Toward the Integration of Complementary Medicine Into Supportive Cancer Care
Eran Ben-Arye, Bella Shulman, Yael Eilon, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Anesthesiology
|
November 27, 2008
Blood transfusion promotes cancer progression: a critical role for aged erythrocytes
Shir Atzil, Michal Arad, Ariella Glasner, et al.
Progress in Neurobiology
|
June 19, 2012
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Shambhu Bhat, David T Dao, Chantelle E Terrillion, et al.
International Journal of Mental Health Systems
|
February 24, 2024
Mapping awareness-raising and capacity-building materials on developmental disabilities for non-specialists: a review of the academic and grey literature
Elisa Genovesi, Yuan Ishtar Yao, Emily Mitchell, et al.
Psychopharmacology
|
August 19, 2008
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat
Mark D Black, Geoffrey B Varty, Michal Arad, et al.
Molecular Neurodegeneration
|
June 26, 2021
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, et al.
Stem Cell Research & Therapy
|
July 29, 2017
Harvesting multipotent progenitor cells from a small sample of tonsillar biopsy for clinical applications
Raju Khatri, Michal Arad, Timothy Ortlip, et al.
Nature Aging
|
April 28, 2023
Alzheimer's disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis
Raz Dvir-Szternfeld, Giulia Castellani, Michal Arad, et al.
Oncogene
|
June 9, 2020
ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype
Benjamin A Portney, Michal Arad, Aditi Gupta, et al.
Psychopharmacology
|
December 25, 2010
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
Mark D Black, Rachel J Stevens, Nancy Rogacki, et al.
Oncology Nursing Forum
|
June 21, 2017
Attitudes Among Nurses Toward the Integration of Complementary Medicine Into Supportive Cancer Care
Eran Ben-Arye, Bella Shulman, Yael Eilon, et al.
Page
of 4